|
|
In Vitro Technology Early studies of drug metabolism verified the central role of the liver. As the only organ positioned between the intestines and systemic blood circulation, this was the logical site for chemical transformation. In vitro techniques utilizing liver tissue became feasible once Potter and Elvehjem developed non-destructive homogenization procedures in 1936. Individual liver organelles could be isolated once A. Claude introduced differential centrifugation in 1941. Gerald Mueller, working in the laboratory of James and Elizabeth Miller, applied these techniques to the study of a rat carcinogen called DAB (dimethylaminoazobenzene). Mueller and Miller showed that DAB was metabolized by rat liver homogenates, and that the process required both oxygen and a reductant (NADPH).
At the age of 35, Axelrod moved to NIH and began studies on sympathomimetic amines, including amphetamine. He wondered why rabbits could rapidly metabolize this compound and what the mechanism might be? When he voiced concerns about his own lack of formal training in enzymology, his co-worker Gordon Tomkins replied "Julie, there's no big mystery to being an enzymologist. All you have to have is a razor blade and a liver." Axelrod found that amphetamine was also rapidly metabolized in liver slices, and learned that NADPH was required as a co-factor. Then he located the sub-cellular site of activity using the methods developed by Hogeboom and Schneider. This newly defined "microsomal" oxidizing system was soon shown to be responsible for metabolism of a wide variety of drugs and other chemicals.
|
|
Index |
Intro | The Beginning | Oxidation |
|